http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S5612308-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c999fee6428152a996011d506925c2d7
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08G65-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-805
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08L71-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-08
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08G65-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08H1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08L71-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-805
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-107
filingDate 1979-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2173f5a4c7ff720f781f3bcd27f45388
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1fbf780844e77f9372e522f59d82b9aa
publicationDate 1981-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-S5612308-A
titleOfInvention Blood substitute
abstract PURPOSE: To provide a high safety blood substitute containing, as an oxygen carrier, a compound having an oxygen-affinity comparable to hemoglobin and sufficiently long life in the blood vessels, and obtained by bonding hemoglobin with a specific polymer. n CONSTITUTION: An addition product of hemoglobin and polyethylene glycol, polypropylene glycol or a copolymer of ethylene glycol and propylene glycol, is used as an oxygen-carrier. The addition reaction is carried out, e.g. by the direct bonding in the presence of a condensing agent such as cyanogen bromide, or by the use of a chemical bonding agent such as cyanuric chloride. The amount of the polymer is 4W150 molecules per 1 molecule of hemoglobin. The life in the blood vessels of the oxygen-carrier thus obtained is 2W4 times that of hemoglobin. The carrier is not converted to the antigen in the blood vessel, and is truly preferable as a safe substitute of blood. n COPYRIGHT: (C)1981,JPO&Japio
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H0564128-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H026337-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2002540081-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S59104323-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S58225025-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H0463053-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S5959629-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-4739530-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S57206622-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7235639-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S6153223-A
priorityDate 1979-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416290180
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10476
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID417430547
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7954
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523291
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1030
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523829
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419545923
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID174
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID977
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226410187

Total number of triples: 45.